“Role of 18F-FDG PET/CT in Assessment of Recurrence and Metastases in Female Breast Carcinoma Patients in Relation to Immunohistochemical Markers: Emphasis on HER2 Status, SUVmax Correlation, and Alignment with 2025/2026 EANM/SNMMI Guidelines”, Bangladesh J. Nuclear Med., vol. 29, no. 1, pp. 28–35, May 2026, doi: 10.3329/bjnm.v29i1.89278.